Skip to main content

Table 2 Descriptive characteristics

From: Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency

Characteristic Group I average results (n =43) Group II average results (n =42) P-value
Age 49.8 49.6 0.98
BMI 35.65 36.0 0.98
WC (cm) 118.64 120.26 0.98
SP (mmHg) 128.43 130.12 0.98
DP (mmHg) 85.26 86.05 0.98
F.test 3.85 3.80 0.98
HbA1c 8.26 8.43 0.98
Leptin 21.46 23.19 0.98
TC 211.17 207.28 0.98
TG 185.6 182.21 0.98
HDL 55.50 54.0 0.98
LDL 102.95 99.58 0.98
  1. Data are expressed as mean ± SD. BMI: body mass index; Chol: cholesterol; DP: diastolic blood pressure; F. test: free testosterone; HbA1c: glycosylated hemoglobin; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; SP: systolic blood pressure; TC: total cholesterol; TG: triglyceride; WC: waist circumference.